
Angewandte Chemie - International Edition p. 4404 - 4407 (2014)
Update date:2022-08-02
Topics:
Johnson, Miles W.
Bagley, Scott W.
Mankad, Neal P.
Bergman, Robert G.
Mascitti, Vincent
Toste, F. Dean
The development of a gold(I)-catalyzed sulfination of aryl boronic acids is described. This transformation proceeds through an unprecedented mechanism which exploits the reactivity of gold(I)-heteroatom bonds to form sulfinate anions. Further in situ elaboration of the sulfinate intermediates leads to the corresponding sulfones and sulfonamides, two pharmacophores routinely encountered in drug discovery. A la mode: A gold(I)-catalyzed synthesis of sulfinates has been accomplished. Preparation of proposed intermediates, X-ray studies, and a number of mechanistic experiments suggest that an unprecedented mode of reactivity for gold(I) has been achieved. The resulting sulfinates from this reaction can be functionalized in situ to form sulfones and sulfonamides.
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Tangshan Moneide Trading Co., Ltd.
Contact:+86-315-8309571
Address:2-7-420 Jidong Building Materials Commercial Center, Tangshan, Hebei, 064000 China
PINGYUAN SIHUAN PHARMACEUTICAL CO., LTD
Contact:+86-531-55696072
Address:#2766,yinxiu Road, Economic Development Zone, Pingyuan Country, Shandong Province, China.
SHANGHAI ARCADIA BIOTECHNOLOGY LTD.
Contact:+86-21-61353236
Address:SUITE 901, BUILDING WENSLI, 1378 LU JIA BANG RD, SHANGAHI 200011, P.R.CHINA
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Doi:10.1039/J39670002091
()Doi:10.1002/ejoc.201500162
(2015)Doi:10.1039/c39930001493
(1993)Doi:10.1021/ja01167a030
(1950)Doi:10.1055/s-1998-1915
(1998)Doi:10.1016/j.tetlet.2020.151780
(2020)